These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 17462115)
1. The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease. Cheong MA; Kim KS; Lee GS Eur J Anaesthesiol; 2007 Sep; 24(9):789-95. PubMed ID: 17462115 [TBL] [Abstract][Full Text] [Related]
2. Neuromuscular interactions between mivacurium and esmolol in rabbits. Kim KS; Kim KH; Shin WJ; Yoo HK Anaesthesia; 1998 Feb; 53(2):140-5. PubMed ID: 9534636 [TBL] [Abstract][Full Text] [Related]
3. Rabbits treated with chronic isepamicin are resistant to mivacurium and rocuronium. Kim KS; Shim JC; Jun JH; Lee KH; Chung CW Anesth Analg; 1999 Mar; 88(3):654-8. PubMed ID: 10072022 [TBL] [Abstract][Full Text] [Related]
4. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury. Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896 [TBL] [Abstract][Full Text] [Related]
5. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Kim KS; Jeon JW; Koh MS; Shim JH; Cho SY; Suh JK Anesth Analg; 2003 Feb; 96(2):438-42, table of contents. PubMed ID: 12538193 [TBL] [Abstract][Full Text] [Related]
6. Effects of succinylcholine on the recovery of block produced by mivacurium in rats. Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002 [TBL] [Abstract][Full Text] [Related]
7. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906 [TBL] [Abstract][Full Text] [Related]
8. Duration of action and hemodynamic properties of mivacurium chloride in dogs anesthetized with halothane. Smith LJ; Moon PF; Lukasik VM; Erb HN Am J Vet Res; 1999 Sep; 60(9):1047-50. PubMed ID: 10490069 [TBL] [Abstract][Full Text] [Related]
9. The interaction of the neuromuscular effects between mivacurium and esmolol in rats. Cheng RY; Hau HR; Sun YC; Chou CD; Liao KC; Chen CF; Tsai SK Acta Anaesthesiol Sin; 1995 Jun; 33(2):97-100. PubMed ID: 7663871 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of mivacurium in pediatric patients. Zeng R; Liu X; Zhang J; Yin N; Fei J; Zhong S; Hu Z; Hu M; Zhang M; Li B; Li J; Lian Q; ShangGuan W BMC Anesthesiol; 2017 Apr; 17(1):58. PubMed ID: 28415988 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block. Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Devlin JC; Head-Rapson AG; Parker CJ; Hunter JM Br J Anaesth; 1993 Aug; 71(2):227-31. PubMed ID: 8123397 [TBL] [Abstract][Full Text] [Related]
14. The mechanism of pancuronium potentiation of mivacurium block: use of the isolated-arm technique. Motamed C; Kirov K; Lieutaud T; Duvaldestin P Anesth Analg; 2000 Sep; 91(3):732-5. PubMed ID: 10960409 [TBL] [Abstract][Full Text] [Related]